Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4742719
Max Phase: Preclinical
Molecular Formula: C48H60N2O6
Molecular Weight: 761.02
Molecule Type: Unknown
Associated Items:
ID: ALA4742719
Max Phase: Preclinical
Molecular Formula: C48H60N2O6
Molecular Weight: 761.02
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC1=C(CCc2ccoc2)[C@@]2(C)CCCC(C)(C)[C@@H]2C/C1=N/OC(=O)c1ccc(C(=O)O/N=C2/C[C@H]3C(C)(C)CCC[C@]3(C)C(CCc3ccoc3)=C2C)cc1
Standard InChI: InChI=1S/C48H60N2O6/c1-31-37(17-11-33-19-25-53-29-33)47(7)23-9-21-45(3,4)41(47)27-39(31)49-55-43(51)35-13-15-36(16-14-35)44(52)56-50-40-28-42-46(5,6)22-10-24-48(42,8)38(32(40)2)18-12-34-20-26-54-30-34/h13-16,19-20,25-26,29-30,41-42H,9-12,17-18,21-24,27-28H2,1-8H3/b49-39-,50-40-/t41-,42-,47+,48+/m0/s1
Standard InChI Key: CTMUMEQHSGMHFO-BLBAOWACSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 761.02 | Molecular Weight (Monoisotopic): 760.4451 | AlogP: 12.27 | #Rotatable Bonds: 10 |
Polar Surface Area: 103.60 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 0 |
#RO5 Violations: 2 | HBA (Lipinski): 8 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: 1.81 | CX LogP: 12.79 | CX LogD: 12.79 |
Aromatic Rings: 3 | Heavy Atoms: 56 | QED Weighted: 0.15 | Np Likeness Score: 0.73 |
1. González-Cofrade L,Oramas-Royo S,Cuadrado I,Amesty Á,Hortelano S,Estevez-Braun A,de Las Heras B. (2020) Dehydrohispanolone Derivatives Attenuate the Inflammatory Response through the Modulation of Inflammasome Activation., 83 (7.0): [PMID:32584575] [10.1021/acs.jnatprod.0c00200] |
Source(1):